ACO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.689000E-01
Normal-vs-Stage2
7.692400E-01
Normal-vs-Stage3
5.410600E-01
Normal-vs-Stage4
7.991000E-01
Stage1-vs-Stage2
6.170400E-01
Stage1-vs-Stage3
2.666200E-01
Stage1-vs-Stage4
8.513000E-01
Stage2-vs-Stage3
2.468600E-01
Stage2-vs-Stage4
9.053600E-01
Stage3-vs-Stage4
3.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.348600E-01
Normal-vs-AfricanAmerican
4.191600E-01
Normal-vs-Asian
8.820000E-01
Caucasian-vs-AfricanAmerican
1.860410E-01
Caucasian-vs-Asian
5.188000E-01
AfricanAmerican-vs-Asian
1.030160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.068400E-01
Normal-vs-Female
8.238600E-01
Male-vs-Female
9.315800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.283400E-01
Normal-vs-Age(41-60Yrs)
6.158400E-01
Normal-vs-Age(61-80Yrs)
8.834800E-01
Normal-vs-Age(81-100Yrs)
9.678000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.147800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.048200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.849200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.841790E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.903200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.519400E-01
Normal-vs-Daily Drinker
9.207800E-01
Normal-vs-Weekly Drinker
5.821000E-01
Normal-vs-Occasional Drinker
9.028600E-01
Normal-vs-Social Drinker
7.653800E-01
Non Drinker-vs-Daily Drinker
6.543800E-01
Non Drinker-vs-Weekly Drinker
8.527700E-02
Non Drinker-vs-Occasional Drinker
6.035800E-01
Non Drinker-vs-Social Drinker
1.292010E-01
Daily Drinker-vs-Weekly Drinker
2.322000E-01
Daily Drinker-vs-Occasional Drinker
9.947400E-01
Daily Drinker-vs-Social Drinker
4.792000E-01
Weekly Drinker-vs-Occasional Drinker
1.999610E-01
Weekly Drinker-vs-Social Drinker
5.783400E-01
Occasional Drinker-vs-Social Drinker
4.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.645400E-01
Normal-vs-Grade 2
8.036400E-01
Normal-vs-Grade 3
7.856400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.511800E-01
Grade 1-vs-Grade 3
6.615600E-01
Grade 1-vs-Grade 4
7.645400E-01
Grade 2-vs-Grade 3
6.223400E-01
Grade 2-vs-Grade 4
8.036400E-01
Grade 3-vs-Grade 4
7.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.685800E-01
Normal-vs-NonDiabetic
9.515600E-01
Diabetic-vs-NonDiabetic
4.781800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.654800E-01
Normal-vs-NoPancreatitis
8.670200E-01
Pancreatitis-vs-NoPancreatitis
5.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.170800E-01
Normal-vs-N1
7.150200E-01
N0-vs-N1
3.703600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.170200E-01
Normal-vs-TP53-NonMutant
5.200600E-01
TP53-Mutant-vs-TP53-NonMutant
4.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
